Medesis Pharma SA
PAR:ALMDP

Watchlist Manager
Medesis Pharma SA Logo
Medesis Pharma SA
PAR:ALMDP
Watchlist
Price: 0.35 EUR Market Closed
Market Cap: €1.8m

Operating Margin

-4 397.8%
Current
No historical data
Comparison unavailable

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-4 397.8%
=
Operating Income
€-3.2m
/
Revenue
€73.1k

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-4 397.8%
=
Operating Income
€-3.2m
/
Revenue
€73.1k

Peer Comparison

Country Company Market Cap Operating
Margin
FR
Medesis Pharma SA
PAR:ALMDP
1.8m EUR
Loading...
IN
Aaswa Trading and Exports Ltd
BSE:512038
24.5T INR
Loading...
UK
Eight Capital Partners PLC
F:ECS
158.4B EUR
Loading...
US
GE Vernova LLC
NYSE:GEV
182.8B USD
Loading...
US
China Industrial Group Inc
OTC:CIND
121B USD
Loading...
US
Schlumberger NV
NYSE:SLB
74.1B USD
Loading...
US
Baker Hughes Co
NASDAQ:BKR
55.2B USD
Loading...
IN
GTV Engineering Ltd
BSE:539479
4.8T INR
Loading...
US
CoreWeave Inc
NASDAQ:CRWV
49.2B USD
Loading...
CH
Galderma Group AG
SIX:GALD
35.2B CHF
Loading...
US
Reddit Inc
NYSE:RDDT
41.7B USD
Loading...

Market Distribution

Lower than 99% of companies in France
Percentile
1st
Based on 2 333 companies
1st percentile
-4 397.8%
Low
-17 526.7% — 1.3%
Typical Range
1.3% — 11.5%
High
11.5% — 89 700%
Distribution Statistics
France
Min -17 526.7%
30th Percentile 1.3%
Median 6.1%
70th Percentile 11.5%
Max 89 700%

Medesis Pharma SA
Glance View

Market Cap
1.8m EUR
Industry
N/A

Medesis Pharma SA operates as a clinical development stage biopharmaceutical company. The company is headquartered in Baillargues, Occitanie. The company went IPO on 2021-02-12. The firm is engaged through its drug delivery technology Aonys in the development of orally administered molecule drug candidates to expand their therapeutic usefulness to address unmet medical needs. Its technology is also being used for collaborative research programs focused on oncology (customized cancer treatment) and radiotherapy (protection of healthy tissue). The Company’s two drug candidates for treating people contaminated following a civil or military nuclear accident are Plutonium decorporation and Cesium decorporation.

ALMDP Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-4 397.8%
=
Operating Income
€-3.2m
/
Revenue
€73.1k
How has Operating Margin changed over time?

Over the last 0 months, Medesis Pharma SA’s Operating Margin has decreased from -4 397.8% to -4 397.8%. During this period, it reached a low of -4 397.8% on Jan 1, 2022 and a high of -4 397.8% on Jan 1, 2022.

Back to Top